BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Nuvation Bio Launches Expanded Access Program in the U.S. for Taletrectinib in ROS1+ NSCLC

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced it has initiated ...

February 04, 2025 | News

Tasso Inc. and ARUP Laboratories Partner in the U.S. to Expand At-Home Blood Testing for Clinical Research

Tasso Inc., the leading provider of patient-centric, clinical grade blood collection solutions, and ARUP Laboratories, the largest nonprofi...

February 04, 2025 | News

England Secures Access to CASGEVY for Sickle Cell Disease Patients Under NHS Agreement

Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY - - Agreement for CASGEVY in transfusion-dep...

February 03, 2025 | News

GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million) in eight projects ...

January 30, 2025 | News

Ryght AI and Cancer Research South Australia Partner to Accelerate Cancer Clinical Trials in Australia with AI

Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier...

January 29, 2025 | News

Australia’s Inventia Life Science Launches RASTRUM™ Allegro to Transform 3D Cell Culture Research

Inventia Life Science has announced the release of RASTRUM™ Allegro, a new development in 3D cell culture technology aimed at addressing challenges i...

January 28, 2025 | News

Thermo Fisher Scientific Introduces Olink® Reveal: Redefining High-Plex Proteomics with Accessibility and Simplicity

Thermo Fisher Scientific, the world leader in serving science, announced the introduction of Olink® Reveal, setting a new standard for affordable,...

January 28, 2025 | News

Azenta Life Sciences Powers UK Biocentre's Expansion with BioArc Ultra™ for Large-Scale Sample Storage

Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample st...

January 27, 2025 | News

Kelun-Biotech Secures NMPA Approval for Tagitanlimab in First-Line Treatment of Nasopharyngeal Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from Natio...

January 24, 2025 | News

Allurion Technologies to Initiate Clinical Study Combining Allurion Program with GLP-1 Therapy to Transform Obesity Care

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its ...

January 24, 2025 | News

Expecto Health Science Partners with Mayapada Hospital Jakarta Selatan to Strengthen Clinical Research in Asia-Pacific

Expecto Health Science, a leading full-service Contract Research Organization (CRO) in Asia Pacific with a focus on emerging economies, announced the signi...

January 24, 2025 | News

Guangzhou Fermion Partners with Simcere to Advance Clinical-Stage SSTR4 Agonist for Pain Management

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited have announced a partnership to develop a clinical-stage pain treatment ass...

January 20, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Stay Connected